CDKN1C and Miyoshi myopathy: Artificial transfer of miR-221/222 inhibitors in MM cells triggered the up-regulation of their target genes, including PTEN, PUMA, p27Kip1, and p57Kip2, thereby exhibited in vitro antiproliferative effects in MM cells.